BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Deals

  Thermo Fisher Scientific Completes Acquisition of Phenom-World

  Thermo Fisher will integrate the business into Thermo Fisher’s Analytical Instruments segment. Terms of the transaction were not disclosed.

  December 29, 2017

   · 

  1 min read
• Policy

  Avadel Pharmaceuticals Issues 2018 Corporate Outlook

  The company announced its 2018 corporate objectives and financial expectations, including the commercial launch of Noctiva.

  December 29, 2017

   · 

  14 min read
• Drug Development

  Atara Biotherapeutics Announces FDA Clearance to Initiate Two Phase III Clinical Studies to Evaluate Tabelecleucel in Patients With Rituximab-Refractory Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV+PTLD)

  Tabelecleucel is Atara’s off-the-shelf T-cell immunotherapy in development for the treatment of EBV+PTLD.

  December 29, 2017

   · 

  9 min read
• Business

  Atara Biotherapeutics to Host Corporate Update Conference Call on Friday, December 29, 2017, at 8:00 a.m. EST

  A replay of the webcast will be available on the Company’s website for 90 days following the live conference call.

  December 29, 2017

   · 

  4 min read
• Business

  CEL-SCI Reports Fiscal 2017 Financial Results and Clinical & Corporate Developments

  CEL-SCI reported a net loss of ($14.36) million in fiscal year 2017 versus a net loss of ($11.51) million in fiscal 2016.

  December 29, 2017

   · 

  5 min read